Evgen Pharma (EVG) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock EVG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsightApril 30, 2025 | finance.yahoo.comBreast Cancer Market to Witness Upsurge in Growth by 2032, According to DelveInsightMarch 27, 2025 | theglobeandmail.comTheraCryf Reports Positive SFX-01 Study ResultsNovember 11, 2024 | markets.businessinsider.comPassing of Dr Sue Foden, ChairNovember 6, 2024 | lse.co.ukPROTAC Market is Expected to Showcase Significant Growth During the Study Period (2020–2034) | DelveInsightAugust 12, 2024 | finance.yahoo.comGlobal Cancer Supportive Care Drugs Market to Cross 17 Billion Mark by 2030| DelveInsightAugust 1, 2024 | finance.yahoo.comEvgen Pharma plc (LON:EVG) Insider Acquires £10,000 in StockApril 6, 2024 | insidertrades.comTRADING UPDATES: Northcoders launches bootcamp; Schroder investsApril 4, 2024 | lse.co.ukEvgen to Raise Up to $2.4 Mln; to Change Name After Acquiring Chronos TherapeuticsMarch 20, 2024 | marketwatch.comEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsFebruary 27, 2024 | lse.co.ukPharma middlemen face govt. scrutiny over generic drug shortagesFebruary 14, 2024 | msn.comEvgen Pharma Share ChatJanuary 26, 2024 | lse.co.ukMetastatic HR+/HER2− Breast Cancer Market is Expected to Showcase a Significant Growth at a CAGR of 9.3% by 2032, Predicts DelveInsightDecember 4, 2023 | finance.yahoo.comEvgen Pharma "delighted" with cash position after promising first halfOctober 31, 2023 | finance.yahoo.comEvgen Pharma hires interim CFO from Faron, chair to retire this monthSeptember 5, 2023 | lse.co.ukEvgen Pharma Chair Barry Clare Steps Down; Appoints New Interim Chair, Interim CFOSeptember 5, 2023 | marketwatch.comEvgen Pharma Shares Rise on Positive SFX-01 Tablet ReportAugust 15, 2023 | marketwatch.comEvgen Pharma Shares Fall on Ending of License DealAugust 2, 2023 | marketwatch.comEvgen collaborator receives grant from KWF Dutch Cancer SocietyJune 19, 2023 | lse.co.ukEvgen Pharma confident amid Stalicla deal; CFO Moulson to retireJune 7, 2023 | lse.co.ukEvgen Pharma Results From SFX-01 Tablet Trial Meet ExpectationsMarch 22, 2023 | marketwatch.comEvgen Pharma Shares Rise on Drug Candidate DataMarch 16, 2023 | marketwatch.comTHG and musicMagpie move to reassure investors as Silicon Valley Bank's UK arm is sold to HSBCMarch 13, 2023 | msn.comEvgen Pharma starts clinical trial of new SFX-01 tabletNovember 16, 2022 | lse.co.ukCORRECT: Coral Products buys Ecodeck; Evgen Pharma recruitsOctober 13, 2022 | lse.co.ukTRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruitsOctober 12, 2022 | lse.co.ukAIM WINNERS & LOSERS: Europa Oil, i3 Energy slide as well disappointsOctober 11, 2022 | lse.co.ukCompanies Like Evgen Pharma (LON:EVG) Are In A Position To Invest In GrowthOctober 11, 2022 | finance.yahoo.comMarket movers: Electricity generators fall on revenue cap reportsOctober 10, 2022 | proactiveinvestors.com.auShares in drug maker more then double after agreeing $160m dealOctober 10, 2022 | msn.comSTALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indicationsOctober 10, 2022 | benzinga.comEvgen Pharma Shares Jump After Securing Licensing Deal for Up to $160.5 MlnOctober 10, 2022 | marketwatch.comEvgen Pharma plc (EVG.L)August 16, 2022 | uk.finance.yahoo.comEvegen Pharma and Michigan University to collaborate in colorectal cancer studyJune 13, 2022 | proactiveinvestors.comEvgen Pharma starts trial to test breast cancer tablet; loss narrowsJune 8, 2022 | lse.co.ukEvgen Pharma Drops on FY 2022 Pretax LossJune 8, 2022 | marketwatch.comEvgen Pharma launches new collaboration for lead assetMay 25, 2022 | proactiveinvestors.comEvgen Pharma expanding its work with the Manchester Breast CentreMarch 7, 2022 | proactiveinvestors.com.auEvgen Pharma Shares Rise on Licensing Deal for Sulforaphane AnaloguesJanuary 19, 2022 | marketwatch.comEvgen signs agreement for Spanish institutions' sulfoaphane analoguesJanuary 18, 2022 | lse.co.ukWe're Not Very Worried About Evgen Pharma's (LON:EVG) Cash Burn RateSeptember 27, 2021 | finance.yahoo.comEvgen Pharma Climbs on FDA Orphan-Drug Designation for Brain Tumor TreatmentSeptember 2, 2021 | morningstar.comMEvgen Pharma PLC (EVG)August 13, 2021 | investing.com Get Evgen Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVG Media Mentions By Week EVG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVG News Sentiment▼0.000.72▲Average Medical News Sentiment EVG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVG Articles This Week▼00▲EVG Articles Average Week Get the Latest News and Ratings for EVG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Evgen Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Glenveagh Properties News Today Minoan Group News Today Unite Group News Today B&M European Value Retail News Today Premier Foods News Today TR Property Investment Trust News Today Baillie Gifford US Growth News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:EVG) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The $100 billion DeFi prediction nobody's talking about The numbers are staggering: $38.5 billion TVL, $1 m...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTime is running out on the most obvious trade in historyGold just broke out to fresh all-time highs, silver is up 40% this year, and for the first time in three decad...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evgen Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evgen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVG Stock Alerts